FolioLanternBeta
UTHRUnited Therapeutics Corp

James Edgemond

CFO and Treasurer at United Therapeutics Corp, as of Jun 23, 2026Sold $212M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
19K
shares held after the latest filing, United Therapeutics Corp
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
398K
shares sold, past 12 months
35
days with sales
$10.1M
largest single day, Dec 1, 2025
1
company filed for

Share of stake sold at United Therapeutics Corp is not shown: the same shares may be reported by another insider. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNov 2025: $38.5M under a disclosed planNovDec 2025: $21.9M under a disclosed planDecJanFebMar 2026: $16.6M under a disclosed planMarApr 2026: $51.4M under a disclosed plan$51.4MAprMay 2026: $45.7M under a disclosed planMayJun 2026: $37.5M under a disclosed planJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
United Therapeutics Corp (UTHR)CFO and TreasurerMar 13, 2015Jun 23, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.